Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15371 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Marzieh Izadifard and 9 co-authors. Institution: Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, …. Major MEDLINE topics: Graft vs Host Disease, MicroRNAs, Hematopoietic Stem Cell Transplantation, Biomarkers. Cited 1 times so far (Crossref); 46 references. Funded by: Tehran University of Medical Sciences, Tehran, Iran, and Student Research Committee, Tehran University of Medical Sciences, Tehran, Iran.
Abstract (original language)
Background
There are currently no laboratory tests that can accurately predict the likelihood of developing acute graft‐versus‐host disease (aGVHD), a patient's response to treatment, or their survival chance. This research aimed to establish circulating miRNAs as diagnostic, prognostic, or predictive biomarkers of aGVHD.
Methods
In a prospective cohort, we studied the incidence of cutaneous aGVHD in AML patients undergoing allo‐HSCT at Shariati Hospital in Tehran, Iran during 2020–2023. Patients with cutaneous aGVHD were labeled as the case group, while patients without cutaneous aGVHD were selected as the control group. Accordingly, the expression levels of six significant miRNAs (miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, miR‐548a‐3p) were evaluated by quantitative reverse transcription–polymerase chain reaction (RTqPCR) in three different time‐points: before transplantation, on day 14 and day 21 after transplantation.
Results
The levels of plasma miR‐455‐3p, miR‐5787, miR‐638, and miR‐3613‐5p were significantly downregulated, while miR‐548a‐3p, and miR‐6511b‐5p were significantly upregulated in individuals with cutaneous aGVHD in comparison to patients without GVHD. Additionally, the possibility for great diagnostic accuracy for cutaneous aGVHD was revealed by ROC curve analysis of differentially expressed miRNAs (DEMs).
Conclusion
The study findings encourage us to hypothesize that the aforementioned miRNAs may contribute to the predominance of aGVHD, particularly low‐grade cutaneous aGVHD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
- Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
ORCID profiles: Marzieh Izadifard, Mohammad Ahmadvand, Hossein Pashaiefar, Kamran Alimoghadam, Amir Kasaeian, Maryam Barkhordar, Ghazal Seghatoleslami, Mohammad Vaezi, Ardeshir Ghavamzadeh, Marjan Yaghmaie
Funding
- Tehran University of Medical Sciences, Tehran, Iran, and Student Research Committee
- Tehran University of Medical Sciences, Tehran, Iran
Cite
APA
Izadifard, M., Ahmadvand, M., Pashaiefar, H., Alimoghadam, K., Kasaeian, A., Barkhordar, M., Seghatoleslami, G., Vaezi, M., Ghavamzadeh, A., & Yaghmaie, M. (2024). Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15371
Vancouver
Izadifard M, Ahmadvand M, Pashaiefar H, Alimoghadam K, Kasaeian A, Barkhordar M, et al. Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15371
BibTeX
@article{Izadifard2024,
author = {Izadifard, Marzieh and Ahmadvand, Mohammad and Pashaiefar, Hossein and Alimoghadam, Kamran and Kasaeian, Amir and Barkhordar, Maryam and Seghatoleslami, Ghazal and Vaezi, Mohammad and Ghavamzadeh, Ardeshir and Yaghmaie, Marjan},
title = {Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15371}
}
EUVIMED